ianalumabSRI-6SRI-4systemic lupus erythematosusSLENCT03656562
…ge: 17W–187W). At W28, higher proportions of patients receiving ianalumab achieved SRI-4 (70.6%), SRI-6 (50.0%), LLDAS (17.6%), DORIS (11…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 601–660 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Sulfasalazine6Tisagenlecleucel6Zonisamide6erlotinib6hydromorphone6oxcarbazepine6Botulinum Toxin A6Calcineurin inhibitors6IL-76MMAE6PD-1 inhibitors6PLEX6Saline6Tezacaftor6abiraterone6anticoagulant6antihypertensive medications6dexketoprofen6oral steroids6phenytoin6sodium bicarbonate6Baclofen6Fluoroquinolone6Itraconazole6PPI6PRAME6Rapamycin6antiseizure medications6mephedrone6n-butyl cyanoacrylate6renin-angiotensin system inhibitors6Beta blocker6Entecavir6Oral corticosteroids6Valganciclovir6anti-seizure medications6cabotegravir/rilpivirine6citalopram6dextran sulfate sodium6penicillins6stimulants6teicoplanin6HRT5Treprostinil5Glimepiride5Orlistat5NKTR-2555Emicizumab5Efgartigimod5Sarilumab5Etrasimod5CAB-LA5D-Dimer5GDF-155TMZ5TAF5Darolutamide5ESPB5Marijuana53TC5
Articles mentioning drugs
10,506 articles · page 98 of 876ANIprednisoneSLESLE-DASKikuchi disease
…loading dose. In addition to corticosteroids and antimalarials, ANI was administered in many cases concomitantly with other immunom…
HydroxychloroquineHCQSLEsystemic lupus erythematosusCKDtertiary referral center
…Objectives Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus …
voclosporinprednisolonelupus nephritisKDIGO 2024
…jectives Following the successful AURORA-1 and AURORA-2 trials, voclosporin was incorporated into the KDIGO 2024 clinical guidelines for th…
Dapirolizumab pegolDZPprednisoneSLESLE-specificLupus
… including fatigue, musculoskeletal pain and morning stiffness. Dapirolizumab pegol (DZP) is a novel CD40L inhibitor with broad modulatory effects …
CannabisUK BiobankCanUDdementia
…up is warranted to confirm these findings.Clinical implications Cannabis use in older adults does not appear linked to faster cognitive …
camrelizumabgemcitabinecisplatinhigh risk nasopharyngeal carcinoma
…se events (grade 3 or 4) occurred in 19 patients (10.2%) in the camrelizumab group.Conclusion The addition of camrelizumab to concurrent che…
azithromycinAzithromycin-resistantchronic lung disease of prematurity
…ably prevalent in the placebo group, with minimal increase with azithromycin treatment, suggesting that, regardless of the additional use of…
ranibizumabavacincaptad pegolACPgeographic atrophynAMDneovascular age-related macular degenerationNCT00709527
…herapy for geographic atrophy, administered in combination with ranibizumab, an approved therapy for neovascular age-related macular degene…
ticagrelorprasugrelclopidogrelaspirincoronary heart diseaseCHDWanfangacute coronary syndromeChina National Knowledge Infrastructure
… P2Y12 receptor antagonist), mainly with low-dose prasugrel and ticagrelor. Off-label low-dose antiplatelet agents significantly reduced m…
ROSE12ipilimumabsolid tumors
… while reducing binding to inhibitory FcγRIIb. In mouse models, ROSE12 monotherapy significantly inhibited tumor growth in both conven…
IPTp-SPsulfadoxine-pyrimethaminemalariaANC
…ers interviewed in Mali (44) and Burkina Faso (41) thought that IPTp-SP delivery through SMC increased ANC attendance and reduced malar…